top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Obesity and Cancer Death Among White and Black Adults
Recent study will inform us about interventions and policies that can reduce disparities in cancer death amongst White and Black Adults.
Women's Cancer Research Foundation
Jan 21, 20222 min read
0 comments
The Importance of Observation
The importance of individual observation though are key to discovery, analysis and development of new treatments and technologies.
Women's Cancer Research Foundation
Jan 6, 20222 min read
0 comments
Chemo Brain Is Real
“Chemo brain” refers to thinking that is sluggish or fuzzy. Essentially, this condition can interfere with executive functioning...
Women's Cancer Research Foundation
Dec 23, 20212 min read
0 comments
Research Breakthrough Could Protect Against Breast Cancer Progression
Scientists from England have been studying the link between antibiotic use and the speed at which mice develop breast cancer.
Women's Cancer Research Foundation
Nov 30, 20211 min read
0 comments
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
In a 2021 study, 1881 patients who received either implant-based or autologous breast reconstruction following neoadjuvant or adjuvant...
Women's Cancer Research Foundation
Nov 24, 20211 min read
0 comments
Aging Cancer Survivors Have Greater Functional Decline
In endeavoring to prevent, mitigate, or reverse the adverse aging-related effects, it is imperative to identify which cancer survivors...
Women's Cancer Research Foundation
Nov 17, 20211 min read
0 comments
Artificial Intelligence and Mammography
Researchers have suggested that artificial intelligence may eventually replace clinical radiologists in process of breast cancer screening.
Women's Cancer Research Foundation
Nov 9, 20211 min read
0 comments
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
Women's Cancer Research Foundation
Nov 5, 20212 min read
0 comments
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.
Women's Cancer Research Foundation
Nov 3, 20211 min read
0 comments
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
Women's Cancer Research Foundation
Oct 30, 20212 min read
0 comments
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
Women's Cancer Research Foundation
Oct 27, 20212 min read
0 comments
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Analyses showed a longer duration of contraceptive use and more recent use were associated with a greater reduction in ovarian cancer risk.
Women's Cancer Research Foundation
Oct 22, 20211 min read
0 comments
Women’s Health: 50 Years of Progress
Over the past 50 years, there have been tremendous advances in women’s health, particularly in treating cardiovascular disease and cancer.
Women's Cancer Research Foundation
Oct 16, 20212 min read
0 comments
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...
Women's Cancer Research Foundation
Oct 14, 20211 min read
0 comments
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.
Women's Cancer Research Foundation
Oct 12, 20211 min read
0 comments
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Initially, pembrolizumab was approved as a monotherapy for patients with microsatellite instability-high recurrent endometrial cancer.
Women's Cancer Research Foundation
Oct 8, 20211 min read
0 comments
Blood Test for Many Cancer Types as Supplement to Screening
The blood test uses next-generation sequencing to analyze the arrangement of circulating cell-free DNA from a blood sample.
Women's Cancer Research Foundation
Oct 5, 20211 min read
0 comments
Use of Hair Products in Relation to Ovarian Cancer Risk
In 2021 study conducted, the authors evaluated the potential impact of carcinogens from hair products that may be absorbed into bloodstream.
Women's Cancer Research Foundation
Sep 20, 20211 min read
0 comments
Cognitive Function After Cancer and Cancer Treatment
Despite these advancements, the delayed effects from chemotherapy have become progressively concerning to patients.
Women's Cancer Research Foundation
Sep 15, 20212 min read
0 comments
Association Between Breastfeeding and Ovarian Cancer Risk
The results from several oncology studies have indicated that breastfeeding is associated with a reduced risk of epithelial ovarian cancer.
Women's Cancer Research Foundation
Sep 3, 20211 min read
0 comments
bottom of page